Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3451 AL 3465

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S.

J Alzheimers Dis. 2020;74(1):213-225. doi: 10.3233/JAD-190434.

Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting

Jung NY, Kim ES, Kim HS, Jeon S, Lee MJ, Pak K, Lee JH, Lee YM, Lee K, Shin JH, Ko JK, Lee JM, Yoon JA, Hwang C, Choi KU, Lee EC, Seong JK, Huh GY, Kim DS, Kim EJ.

J Alzheimers Dis. 2020;74(2):473-490. doi: 10.3233/JAD-191109.

Down syndrome and dementia: advances in the field

McGlinchey E, McCallion P, McCarron M.

Curr Opin Psychiatry. 2020 May;33(3):278-283. doi: 10.1097/YCO.0000000000000589.

18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease

Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I.

J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.

Interactions between Personality, Depression, Anxiety and Cognition to Understand Early Stage of Alzheimer's Disease

Zufferey V, Gunten AV, Kherif F.

Curr Top Med Chem. 2020;20(9):782-791. doi: 10.2174/1568026620666200211110545.

The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum

Banning LCP, Ramakers IHGB, Köhler S, Bron EE, Verhey FRJ, de Deyn PP, Claassen JAHR, Koek HL, Middelkoop HAM, van der Flier WM, van der Lugt A, Aalten P; Alzheimer's Disease Neuroimaging Initiative; Parelsnoer Institute Neurodegenerative Diseases study group.

Am J Geriatr Psychiatry. 2020 Jul;28(7):735-744. doi: 10.1016/j.jagp.2020.01.012. Epub 2020 Feb 20.

Association between atherosclerosis and Alzheimer's disease: A systematic review and meta-analysis

Xie B, Shi X, Xing Y, Tang Y.

Brain Behav. 2020 Apr;10(4):e01601. doi: 10.1002/brb3.1601. Epub 2020 Mar 11.

Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?

Mullane K, Williams M.

Biochem Pharmacol. 2020 Jul;177:113945. doi: 10.1016/j.bcp.2020.113945. Epub 2020 Apr 2.

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

Zetterberg H, Bendlin BB.

Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.

Proteomics as a reliable approach for discovery of blood-based Alzheimer's disease biomarkers: A systematic review and meta-analysis

Rehiman SH, Lim SM, Neoh CF, Majeed ABA, Chin AV, Tan MP, Kamaruzzaman SB, Ramasamy K.

Ageing Res Rev. 2020 Jul;60:101066. doi: 10.1016/j.arr.2020.101066. Epub 2020 Apr 12.

The role of neurofilament light chain in frontotemporal dementia: a meta-analysis

Karantali E, Kazis D, Chatzikonstantinou S, Petridis F, Mavroudis I.

Aging Clin Exp Res. 2021 Apr;33(4):869-881. doi: 10.1007/s40520-020-01554-8. Epub 2020 Apr 18.

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment

Liu W, Lin H, He X, Chen L, Dai Y, Jia W, Xue X, Tao J, Chen L.

Transl Psychiatry. 2020 Apr 29;10(1):125. doi: 10.1038/s41398-020-0801-2.

Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer's Disease

de Heus RAA, de Jong DLK, Rijpma A, Lawlor BA, Olde Rikkert MGM, Claassen JAHR.

J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2169-2176. doi: 10.1093/gerona/glaa129.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias